| Home Market Dynamics Sector Analysis Company Insights AI Investing Strategies Contact Us Login |
| Recent advancements in weight-loss drug development have positioned Eli Lilly as a leader in obesity management, especially with its effective pharmaceutical options receiving high acceptance as primary treatments. The strong demand for these products underscores the company's successful and innovative approach to product development, with notable successes like the promising outcomes of its ulcerative colitis drug, Omvoh. Together, these developments reflect Eli Lilly's robust capabilities in delivering impactful health solutions and enhancing market performance. However, ongoing competitive pressures in the pharmaceutical sector could pose risks to maintaining this momentum. |
| The price action of Eli Lilly (LLY) is impacted by broad market risk appetite, sector price trend, company-specific performance and market structure. The market sentiment at 0.5 is modestly bullish. Trend sentiment measures the current trend of the stock price, and market sentiment reflects what market participants collectively think where the price will move next.There is no clear direction for LLY since trend sentiment and market sentiment are at the opposite directions. The positive sentiment force for sector is at 0.7, and the negative at -0.2 on 2025-10-07. The forces of and Valuation Sentiment (-1) will drive down the price. The forces of Stock Price Trend (0), Sector Price Trend (0), Price Level Sentiment (0), Option Sentiment (0), Market Risk Appetite (0), and Sentiment towards Fundamentals (4) will drive up the price. The sentiment for Sector Price Trend is calculated based on the price trend of related sector ETF. The sentiment for Option Speculation is calculated from put/call ratio. The Risk Appetite is calculated from Bitcoin price trend. Price Level sentiment is positive when oversold, and negative when overbought. Valuation Sentiment, and Sentimentals towards Fundamentals are extracted from headlines and market commentary. All sentiment scores are normalized on a -10 - +10 scale. The price level reaches 100 at Bollinger upper band, and zero at lower band. |
| LLY | |||||||||||||
| Date | Attention | Price | Price Level | Change | SMA10 Trend | Trend Sentiment | Hourly Trend | Hourly StdDev | Market Sentiment | Action | P | Fund. | News Sentiment |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-10-07 | 0%(0%) | 0 | 0% | 0.5 | 4 | -1 | |||||||
| 2025-10-06 | 0%(0%) | 0 | 0% | 0.4 | 3.6 | -1 | |||||||
| 2025-10-05 | 0%(0%) | 0 | 0% | 0.4 | 3.5 | -1 | |||||||
| 2025-10-04 | 0%(0%) | 0 | 0% | 0.4 | 3.5 | -1 | |||||||
| 2025-10-03 | 0%(0%) | 0 | 0% | 0.2 | 2.2 | 4 | |||||||
| 2025-10-02 | 0%(0%) | 0 | 0% | 0.2 | 1.9 | -1 | |||||||
| 2025-10-01 | 0%(0%) | 0 | 0% | 0 | 1 | 6 | |||||||
| 2025-09-30 | 0%(0%) | 0 | 0% | -0.1 | 0.3 | -1 | |||||||
| 2025-09-29 | 0%(0%) | 0 | 0% | -0.1 | 0.7 | -1 | |||||||
| 2025-09-28 | 0%(0%) | 0 | 0% | -0.1 | 0.4 | -1 | |||||||
| Wait action is recommended in three scenarios with either high uncertainty or high risk: 1. The trend sentiment and market sentiment are at the opposite directions. 2. Both trend sentiment and market sentiment are positive, but the price level is elevated. 3. Both trend sentiment and market sentiment are negative, but the price level is depressed. In an uptrend, as an investor, you may want to wait for the pullback to open long position. In a downtrend, the price will likely rebound after huge decline. As an investor, you may want to wait for the rebound to exit long position. | |||||||||||||
| Market sentiment will accelerate the current trend when both trend sentiment and market sentiment are at the same direction. Market sentiment will generate volatility when it's at the opposite direction of the trend sentiment. News sentiment measures the daily emotion of the market. News sentiment may impact the daily price change while market sentiment is a more stable and consistent moving force. | |||||||||||||
| 2025-10-07 17:02:32 The dynamics of the pharmaceutical industry are reflected in Eli Lilly's strategies and market moves, making it a focal point for investors and analysts. |
| 2025-10-07 17:02:32 Increased investor interest in Eli Lilly indicates confidence in its earnings potential and overall market position. |
| 2025-10-07 17:02:32 Eli Lilly's innovative product Omvoh is showing promising long-term outcomes for ulcerative colitis, highlighting the company's strength in product development. |
| 2025-10-07 17:02:32 The transition of Peter Marks from the FDA to Eli Lilly signifies strategic leadership moves that could enhance the company's position in the pharmaceutical industry. |
| 2025-10-07 17:02:32 Eli Lilly's stock has experienced significant recovery and growth, driven by market optimism and product success. |